CLINE SCIENTIFIC HAS STARTED TESTING THEIR DIAGNOSTIC PROTOTYPE FOR METASTASIZING CANCERS ON LIVE PATIENT MATERIAL WITH CLINICAL RESEARCHERS AT A SWEDISH HOSPITAL
Gothenburg, Sweden (February 13 2020): Cline Scientific will have begun to utilize live tumor cells directly from cancer patients to develop and test their diagnostic prototype for metastasizing cancers to bring this technology to marketThe tumor cells originate from biopsies taken from patients with benign or metastatic tumors. Cline’s prototype has shown promising results in differentiating metastatic from benign tumor cells. Testing on live patient material is a necessary technical step to test how cells from patient biopsies behave before the company is able to initiate clinical